Kubes P, Granger D N
Department of Physiology, University of Calgary, Alberta, Canada.
Am J Physiol. 1992 Feb;262(2 Pt 2):H611-5. doi: 10.1152/ajpheart.1992.262.2.H611.
We recently demonstrated that inhibitors of nitric oxide (NO) production cause a dramatic increase in leukocyte adherence and emigration in postcapillary venules. The objective of this study was to assess whether inhibition of NO production leads to vascular protein leakage and increased microvascular permeability in feline small intestine and to determine whether adherent leukocytes contribute to these responses. Whereas NG-nitro-L-arginine methyl ester (L-NAME) produced fivefold increases in microvascular fluid and protein fluxes, capillary pressure remained unchanged. In some experiments, venous pressure was elevated and the microvascular reflection coefficient for total proteins (sigma d) was estimated from lymph to plasma protein concentration ratio at high capillary filtration rates. L-NAME infusion increased 1 - sigma d (permeability index) from a control value of 0.21 +/- 0.02 to 0.41 +/- 0.07. All of the L-NAME-induced microvascular alterations were completely reversed by nitroprusside. Some animals were pretreated with a monoclonal antibody (MoAb IB4) directed against the leukocyte adhesion glycoprotein complex CD11/CD18. MoAb IB4 did not prevent the initial rise in vascular protein leakage but greatly attenuated the later (30-60 min) phase of enhanced vascular protein leakage. Local intra-arterial infusion of the NO synthesis inhibitor L-NAME (0.025 mumol.ml-1.min-1) produced a profound increase in leukocyte adhesion in postcapillary venules that was partly reversed by sodium nitroprusside administration (0.025 mumol.ml-1.min-1). These results suggest that inhibition of NO production by vascular endothelium leads to a reversible increase in microvascular protein efflux that is mediated by both leukocyte-dependent and -independent mechanisms.
我们最近证实,一氧化氮(NO)生成抑制剂可导致毛细血管后微静脉中白细胞黏附和移出显著增加。本研究的目的是评估抑制NO生成是否会导致猫小肠血管蛋白渗漏和微血管通透性增加,并确定黏附的白细胞是否参与这些反应。尽管NG-硝基-L-精氨酸甲酯(L-NAME)使微血管液体和蛋白通量增加了五倍,但毛细血管压力保持不变。在一些实验中,静脉压力升高,通过在高毛细血管滤过率下测定淋巴与血浆蛋白浓度比来估算总蛋白的微血管反射系数(σd)。输注L-NAME使1 - σd(通透性指数)从对照值0.21±0.02增加至0.41±0.07。硝普钠可完全逆转L-NAME诱导的所有微血管改变。一些动物预先用针对白细胞黏附糖蛋白复合物CD11/CD18的单克隆抗体(MoAb IB4)进行处理。MoAb IB4不能阻止血管蛋白渗漏的初始增加,但可大大减轻后期(30 - 60分钟)血管蛋白渗漏增强阶段。局部动脉内输注NO合成抑制剂L-NAME(0.025 μmol·ml⁻¹·min⁻¹)可使毛细血管后微静脉中的白细胞黏附显著增加,硝普钠给药(0.025 μmol·ml⁻¹·min⁻¹)可部分逆转这种增加。这些结果表明,血管内皮细胞抑制NO生成会导致微血管蛋白外渗可逆性增加,这是由白细胞依赖性和非依赖性机制共同介导的。